Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

✍ Scribed by Y. Miao; D. Dobre; H. J. Lambers Heerspink; B. M. Brenner; M. E. Cooper; H.-H. Parving; S. Shahinfar; D. Grobbee; D. de Zeeuw

• Book ID: 105820304
• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 47 KB
• Volume: 54
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-011-2215-4